FDA was asked by House Energy and Commerce Committee to turn over the results of so called Seas study from Oxford University. The reason is obvious: this study shocked medical society as well as investors. The researchers from Oxford University found thatrisk of cancer in the group of patients taking Vytorin, was unexpectedly higher, then in the control group. Explanation: link between Vytorin and cancer impossible (?!). The funny thing is, that Seas study results were submitted to FDA but was not submitted to House Commerce Committee, which is investigating the safety of the prescription drugs. So my question is: can we trust FDA? I think everybody knows the answer.
health, Vytorin, cancer
Technorati Tags: health, Vytorin, cancer
You may also find interesting
This entry was posted on Saturday, August 2nd, 2008 at 4:38 pm and is filed under Do you know, General health. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
